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Abstract
Pro-inflammatory cytokines cause pancreatic beta cell failure during the development of
type 2 diabetes. This beta cell failure associates with mitochondrial dysfunction, but the
precise effects of cytokines on mitochondrial respiration remain unclear. To test the hypoth-
esis that pro-inflammatory cytokines impair glucose-stimulated insulin secretion (GSIS) by
inhibiting oxidative ATP synthesis, we probed insulin release and real-time mitochondrial
respiration in rat INS-1E insulinoma cells that were exposed to a combination of 2 ng/mL
interleukin-1-beta and 50 ng/mL interferon-gamma. We show that 24-h exposure to these
cytokines dampens both glucose- and pyruvate-stimulated insulin secretion (P < 0.0001
and P < 0.05, respectively), but does not affect KCl-induced insulin release. Mirroring secre-
tory defects, glucose- and pyruvate-stimulated mitochondrial respiration are lowered after
cytokine exposure (P < 0.01). Further analysis confirms that cytokine-induced mitochondrial
respiratory defects occur irrespective of whether fuel oxidation is coupled to, or uncoupled
from, ATP synthesis. These observations demonstrate that pro-inflammatory cytokines
attenuate GSIS by restricting mitochondrial pyruvate oxidation capacity. Interleukin-1-beta
and interferon-gamma also increase mitochondrial superoxide levels (P < 0.05), which may
reinforce the inhibition of pyruvate oxidation, and cause a modest (20%) but significant (P <
0.01) loss of INS-1E cells. Cytokine-induced INS-1E cell failure is insensitive to palmitoleate
and linoleate, which is at odds with the cytoprotection offered by unsaturated fatty acids
against harm caused by nutrient excess. Our data disclose a mitochondrial mechanism for
cytokine-impaired GSIS in INS-1E cells, and suggest that inflammatory and nutrient-related
beta cell failure emerge, at least partly, through distinct paths.
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Introduction
Impaired glucose-stimulated insulin secretion (GSIS) by pancreatic beta cells (β-cells) contrib-
utes to the hyperglycemic state that characterizes type 2 diabetes [1]. While certain conditions
are strongly associated with this impairment, for example the excessive nutrient levels that cir-
culate in obesity [2], the pathological mechanism of β-cell dysfunction in type 2 diabetes is
incompletely understood. Several symptoms and complications of type 2 diabetes involve acti-
vation of the immune system and a consequent state of chronic low-grade inflammation [3,4].
Inflammation is associated with impaired β-cell function [4,5] and decreased β-cell mass [6,7].
The cause of β-cell inflammation in type 2 diabetes is debated, but likely relates to obesity as it
is widely accepted that elevated nutrient levels stimulate the expression of interleukin-1β (IL-
1β) in human pancreatic islets, via activation of the NLRP3 inflammasome [8–10] or the NF-
κB pathway [11], which causes a pro-inflammatory state [12]. In turn, IL-1β upregulates
numerous other cytokines and chemokines [13,14] and indeed reinforces its own expression
causing a vicious cycle [15]. Chronic upregulation of pro-inflammatory cytokines is regarded a
hallmark for impaired insulin secretion [5] and increased β-cell apoptosis [5] in the pathophys-
iology of type 2 diabetes.
The precise mechanisms by which cytokines alter β-cell function and mass have not been
established conclusively. Cytokine-induced β-cell failure is likely mediated by nitric oxide (NO)
that results from activation of inducible nitric oxide synthase [16], but NO-independent inflam-
matory mechanisms have also been suggested [17–19]. Cytokine-provoked NO may inhibit
glycolysis [20–24] and/or the mitochondrial TCA cycle [25,26], but functional bioenergetic con-
sequences of such inhibition have not been demonstrated to date. It is worth notice in this
respect that NO may in fact benefit the bioenergetics of inflamed cells as it stimulates mitochon-
drial biogenesis under certain circumstances [27]. Moreover, it remains unclear if and how
inflammatory GSIS defects relate mechanistically to β-cell failure caused by nutrient excess [28].
Mitochondria are essential for GSIS as glucose-fueled oxidative ATP synthesis causes a rise
in the cytosolic ATP/ADP ratio, which triggers the electrophysiological events that are responsi-
ble for the eventual exocytosis of insulin-containing granules [29]. Moreover, β-cells fully
depend on mitochondria to meet the high energy cost of insulin synthesis (cf. [30]) and exocyto-
sis [31,32] because they are unable to make ATP via anaerobic glycolysis [29]. As mitochondrial
dysfunction has indeed been associated with β-cell failure [33] and because mitochondrial tar-
gets of cytokine-induced NO have been reported [25,26], we set out to explore possible effects
of pro-inflammatory cytokines on real-time mitochondrial activity of INS-1E insulinoma cells.
Here we use IL-1β and interferon-gamma (IFN-γ) to model the inflammatory milieu in diabetes
and show that these cytokines attenuate GSIS and dampen both glucose-sensitivity and cou-
pling efficiency of oxidative phosphorylation. Concomitantly, these cytokines increase mito-
chondrial superoxide production and provoke a modest (20%) cell loss. Detailed real-time
respiratory analysis reveals that IL-1β and IFN-γ impair ATP synthesis and, consequently, GSIS
by restricting the mitochondrial capacity for oxidizing pyruvate.
Materials and methods
Cell culture
Rat INS-1E insulinoma cells (RRID: CVCL_0351), a well-established pancreatic beta-cell
model [34] were maintained in RPMI-1640 medium containing 11 mM glucose, 5% (v/v) fetal
bovine serum (FBS), 10 mM Hepes, 1 mM sodium pyruvate, 50 U/mL penicillin, 50 μg/mL
streptomycin, 500 μM β-mercaptoethanol and 2 mM GlutaMAX [34]. Cells were seeded at 6 x
104 cells/well and, at 70–80% confluence, exposed to a mixture of 2 ng/mL IL-1β and 50 ng/
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mL IFN-γ, in the absence or presence of non-esterified fatty acids (NEFAs), for 24 hr in RPMI
medium containing 11 mM glucose. Notably, the applied cytokine concentrations are used
throughout the literature [11,17,35–37], as they reflect pathological levels observed during the
development of diabetes. Palmitoleate and linoleate were conjugated to bovine serum albumin
(BSA) at molar ratios of 2:1 and 4:1, respectively, yielding free fatty acid levels of 20 nM as esti-
mated assuming binding parameters reported by Huber et al. (2006) [38]. FBS was omitted
from the growth medium for NEFA experiments.
Insulin secretion
INS-1E cells seeded and exposed to cytokines ±NEFAs on 96-well culture plates were washed and
starved for 1 h at 37 oC under air in low-glucose Krebs-Ringer Hepes (KRH) medium comprising
135 mM NaCl, 3.6 mM KCl, 10 mM Hepes (pH 7.4), 0.5 mM MgCl2, 1.5 mM CaCl2, 0.5 mM
NaH2PO4, 2 mM GlutaMAX, 2.5 mM glucose and 0.2% (w/v) BSA. Assay buffer was then replaced
with fresh KRH medium and cells were incubated for 30 min on a shaking plate incubator (Labnet
International, Oakham, UK) at 100 rpm. Next, supernatants were collected on ice and replaced
with KRH containing either 20 mM glucose, 5 mM sodium pyruvate or 30 mM KCl. After another
30-min incubation, supernatants were collected on ice. Supernatants were centrifuged at 1,000g to
pellet any detached cells and assayed for insulin by enzyme-linked immunosorbent assay (#10-
1247-01, Mercodia, Sweden) or homogenous time-resolved fluorescence (#62IN1PEG, Cisbio Bio-
assays, France). Secreted insulin was normalized to cell density (see below).
Mitochondrial respiration and superoxide
Mitochondrial respiration was measured in intact attached INS-1E cells as described in detail
before [39]. Briefly, INS-1E cells seeded and treated with cytokines ± NEFAs on XF24 cell cul-
ture plates (Seahorse Bioscience, Agilent Technologies) were washed into KRH assay buffer
and incubated for 50 min at 37 oC under air. XF24 plates were then transferred to a Seahorse
XF24 extracellular flux analyzer (controlled at 37˚C) for a 10-min calibration and 4 measure-
ment cycles to record basal cellular respiration. Glucose or sodium pyruvate were added at 20
and 5 mM, respectively, to stimulate respiration. Subsequently, 2 μg/mL oligomycin or 3 μM
BAM 15 (Tocris Bioscience, Bristol, UK) and a mixture of 2 μM rotenone plus 2 μM antimycin
A were added sequentially to, respectively, inhibit the ATP synthase or uncouple oxidative
phosphorylation, and determine non-mitochondrial respiration. Superoxide was determined
by monitoring MitoSOX and DHE (hydroethidine) oxidation in time as described before [40].
Cell density
Density of attached cells was determined in 96-well plates by 4’,6-diamidino-2’-phenylindole
dihydrochloride (DAPI) fluorescence [40]. Cells seeded and treated with cytokines ±NEFAs were
washed with phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde (ThermoFisher
Scientific, #28908). After fixation, cells were washed again in PBS and then loaded with 0.5 μg/mL
DAPI. To limit background detection after loading with DAPI, cells were washed 4 times with
PBS. DAPI fluorescence (λex/em = 350/460 nm) was detected using a PHERAstar FS plate reader
(BMG LABTECH) in fluorescence intensity, bottom-reading and well-scanning mode.
Statistical analysis
Significance of mean differences was tested by unpaired Student’s t-tests or two-way ANOVA
with Sidak multiple comparison analysis using GraphPad Prism Version 6.0 for Mac OS X
(GraphPad software, San Diego, CA, USA). Data are presented as means ± SEM.
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Results and discussion
Cytokines concomitantly impair GSIS and lower mitochondrial ATP
synthesis
INS-1E insulinoma cells retain many characteristics of primary β-cells, including glucose-sens-
ing ability, which is why they are a widely used β-cell model [34]. In this study, INS-1E cells
increased their insulin secretion rate 2.7-fold in response to 20 mM glucose, a stimulation that
lowered to 1.4-fold when cells had been exposed to a mixture of IL-1β (2 ng/mL) and IFN-γ
(50 ng/mL) for 24 h (Fig 1A). Cytokine attenuation of GSIS is owing to decreased insulin
release at a stimulatory glucose level since basal insulin release was unaffected (Fig 1A), which
is consistent with the deleterious effects of pro-inflammatory cytokines (including IL-1β, IFN-
γ and TNF-α) on insulin secretion reported by others [21,41,42]. Notably, cytokine-induced
GSIS impairment thus differs from nutrient-provoked secretory defects, which are predomi-
nantly owing to stimulated basal insulin release [43]. Pyruvate stimulates insulin secretion to
the same extent as glucose, and does so in a cytokine-sensitive manner, whereas KCl-induced
insulin secretion is unaffected by cytokines (Fig 1A). Pyruvate stimulation of beta cell activity
is not exclusive to insulinoma cells, as insulin secretion by isolated mouse islets is increased to
the same extent in response to methyl-pyruvate as to glucose [44]. These data thus demon-
strate that secretory defects emerge downstream from glycolysis and upstream from β-cell
electrophysiology. Therefore, we determined how cytokines affected glucose-fuelled oxidative
phosphorylation. Mirroring the GSIS phenotype, mitochondrial respiration in cytokine-
exposed cells was stimulated significantly less by glucose (1.7-fold) than respiration in control
cells—2.8-fold stimulation–(Fig 1B). This significant loss of glucose sensitivity is owing to
decreased respiration at a high glucose level (Fig 1B) and is consistent with GSIS data. Like
basal insulin release, basal mitochondrial respiration was unaffected by cytokines (Fig 1B). To
establish the proportion of glucose-stimulated respiration that is used to make ATP, we inhib-
ited respiration with oligomycin. Fig 1C shows that the oligomycin-sensitive oxygen uptake
rate was 3.6 fmol oxygen/min/cell on average and the oligomycin-insensitive rate was 2.4 fmol
oxygen/min/cell. Notably, IL-1β and IFN-γ lowered oligomycin-sensitive respiration, i.e., oxy-
gen consumption coupled to ATP synthesis, whereas they left oligomycin-resistant respiration,
i.e, oxygen consumption linked to mitochondrial proton leak, unaffected (Fig 1C). Conse-
quently, cytokine exposure lowers coupling efficiency of oxidative phosphorylation from
62 ± 0.4% to 56 ± 1.0% (Fig 1D). This coupling efficiency phenotype is statistically significant
(P< 0.05) and shows that cytokine exposure decreases the proportion of mitochondrial respi-
ration used to make ATP [45]. Cytokine-induced impairment of GSIS thus coincides with dys-
functional oxidative phosphorylation, which suggests that deficient mitochondrial ATP
synthesis is responsible for the insulin secretory defect.
Cytokines restrict mitochondrial pyruvate oxidation capacity
To better understand how cytokines inhibit mitochondrial ATP synthesis, we probed their
effect on oxidative phosphorylation in more detail. Interestingly, glucose stimulation of respi-
ration appeared most pronounced in the presence of BAM 15 (Fig 2A), a protonophore that
uncouples oxidative phosphorylation. Uncoupled mitochondrial oxygen uptake is not con-
trolled by ATP synthesis or ATP turnover, and thus generally reflects the capacity of cells for
oxidizing fuel. The fuel oxidation capacity of INS-1E cells thus appears limited by the concen-
tration of glucose (Fig 2B), which sits well with the glucose sensitivity of oxidative phosphory-
lation of pancreatic β-cells [46,47]. Cytokine exposure inhibits both coupled and uncoupled
mitochondrial respiration (Fig 2B), which shows the respiratory inhibition emerges from a
Mechanisms of cytokine-induced defects in pancreatic beta-cell insulin secretion
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negative effect on glucose oxidation. Identical data were obtained when respiration was stimu-
lated with pyruvate instead of glucose (Fig 2D). Pyruvate increases coupled (Fig 2C) and
uncoupled (Fig 2D) mitochondrial oxygen consumption to the same extent as glucose, and the
cytokine sensitivity of stimulated respiration is independent of fuel type Fig 2C and 2D. These
respiratory data show that cytokines impair INS-1E cell function through inhibition of
Fig 1. Cytokine-induced GSIS impairment and oxidative phosphorylation defects. Cells were grown in fully supplemented RPMI (black bars) or exposed
for 24 h to a combination of 2 ng/mL IL-1β plus 50 ng/mL IFN-γ (grey bars). The rate of insulin secretion was normalized to cell number (A) and was
measured at 2.5 mM glucose (G2.5), 20 mM glucose (G20), 5 mM sodium pyruvate (PYR) or 30 mM KCl. Absolute mitochondrial respiration normalized
to cell number was measured ± 20 mM glucose (B)—grey and black bars, respectively. Glucose-stimulated respiration used to make ATP or associated with
proton leak was determined as oligomycin-sensitive or oligomycin-resistant mitochondrial oxygen uptake, respectively (C)—black and grey bars,
respectively. Coupling efficiency of oxidative phosphorylation was calculated as the percentage of glucose-stimulated oxygen uptake used to make ATP (D).
Data are means ± SEM from 3–7 individual experiments (S1 Data) with each condition repeated 3–5 times. Statistical significance of mean differences was
tested by 2-way ANOVA: asterisks indicate statistically significant differences from equivalent RPMI controls (P< 0.05 and P< 0.001). a, ab differs from
the low-glucose condition (P< 0.05 and P< 0.001, respectively).
https://doi.org/10.1371/journal.pone.0199505.g001
Mechanisms of cytokine-induced defects in pancreatic beta-cell insulin secretion
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pyruvate oxidation, which is consistent with our GSIS data (Fig 1). The data rule out that IL-1β
and IFN-γ exerted inflammatory effects upstream from mitochondria under the exposure con-
ditions we applied.
Fig 2. Cytokine-induced restriction of mitochondrial pyruvate oxidation. (A) mean respiratory traces illustrating the
effect of glucose on coupled and uncoupled oxygen uptake. Cells were incubated in glucose-free KRH and then subjected to
20 mM glucose after 5 basal respiratory measurements (grey symbols)–the glucose level was not changed in control cells
(black symbols). Subsequently, respiration was stimulated with 3 μM BAM 15 and then inhibited with a mix of 2 μM
rotenone and 2 μM antimycin A (R/A). (B) cells were grown in fully supplemented RPMI (control) or exposed for 24 h to 2
ng/mL IL-1β plus 50 ng/mL IFN-γ. Mitochondrial respiration was uncoupled with 3 μM BAM 15 in the presence or absence
of 20 mM glucose (grey and black symbols, respectively). Panels (C) and (D) cells were grown in full RPMI (black bars) or
were exposed to 2 ng/mL IL-1β plus 50 ng/mL IFN-γ (grey bars). Respiration was stimulated with 20 mM glucose (HG) or 5
mM sodium pyruvate (PYR) in the absence (C) or presence (D) of 3 μM BAM 15, and substrate responses were normalized
to basal oxygen uptake measured without added substrate–control cells were not stimulated by fuel (LG). Data are
means ± SEM from 3 individual experiments (S1 Data) with each condition repeated 3–4 times. Mean differences were
tested for statistical significance by 2-way ANOVA. (B)  ,differs from the no-glucose condition (P< 0.05 and P< 0.001,
respectively); adiffers from high-glucose control condition (P< 0.01). Panels (C) and (D)  ,cytokine and control
conditions differ (P < 0.05 and P< 0.01, respectively).
https://doi.org/10.1371/journal.pone.0199505.g002
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Cytokines increase mitochondrial superoxide and cause cell loss
Pro-inflammatory cytokines are known to provoke production of reactive oxygen species
(ROS) in β-cells [48] and, consistently, IL-1-β plus IFN-γ exposure increases the rate at which
INS-1E cells oxidize MitoSOX ~ 2-fold (Fig 3A). MitoSOX is a mitochondria-targeted hydro-
ethidine(DHE)-based probe that is widely used to detect superoxide, although it should be
noted that the probe can also be oxidized by hydrogen peroxide (in the presence of peroxi-
dases) and intracellular oxidases [49]. It is conceivable that cytokine-induced mitochondrial
ROS are owing to the restricted pyruvate oxidation capacity. Oxidation of non-targeted DHE
Fig 3. Cytokine-induced mitochondrial superoxide. (A) cells were grown in full RPMI (black bars) or were exposed for 24 h to 2 ng/mL IL-1β
plus 50 ng/mL IFN-γ (grey bars). MitoSOX (A) and DHE (B) oxidation rates were measured without added glucose as described before [40] and
the presented data are means of 3 independent experiments with each condition repeated 4–5 times. Mean differences were tested for statistical
significance by unpaired Student’s t-tests: differs from the control condition (P< 0.05). Glucose-stimulated mitochondrial respiration (C) and
glucose-stimulated insulin secretion (D) correlate inversely with the MitoSOX oxidation rate as confirmed by Pearson correlation analysis
(P< 0.01 and P< 0.05, respectively). Data are stand alone repeats and were collected from 3 independent experiments (S1 Data).
https://doi.org/10.1371/journal.pone.0199505.g003
Mechanisms of cytokine-induced defects in pancreatic beta-cell insulin secretion
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is not affected by cytokine exposure (Fig 3B). Glucose-stimulated mitochondrial respiration
(Fig 3C) and glucose-stimulated insulin secretion (Fig 3D) both correlate inversely with Mito-
SOX oxidation rate, suggesting the possibility that cytokine-induced superoxide reinforces the
inhibition of pyruvate oxidation that accounts for GSIS impairment. The cytokine effect on
MitoSOX oxidation (Fig 3A) is reminiscent of that induced by NEFAs: 24-h palmitate expo-
sure, against a high-glucose background, increases mitochondrial superoxide, an effect that
correlates strongly with the loss of INS-1E cells and, notably, is largely prevented by palmitole-
ate, the monounsaturated counterpart of palmitate [40,50]. In contrast, unsaturated NEFAs do
not attenuate cytokine-stimulated superoxide, as neither linoleate nor palmitoleate signifi-
cantly lowers the cytokine-provoked MitoSOX oxidation rate seen in BSA-treated control cells
(Fig 4A). Exposure to IL-1-β plus IFN-γ causes a 20% decrease of cell density (Fig 4B), which is
likely owing to ROS-induced apoptosis [51,52], however we cannot exclude other mechanisms
of cytokine-induced beta-cell death which have also been suggested [53,54]. This 20% decrease
is small compared to that caused by palmitate [40,50] and, importantly, is not prevented by
linoleate or palmitoleate (Fig 4B). Together, these data suggest that cytokine-induced genera-
tion of ROS and associated loss of cell density are mechanistically unrelated to palmitate-
induced changes in ROS production. Cytokine inhibition of mitochondrial respiration (Fig
4C) and insulin secretion in response to 20 mM glucose (Fig 4D) are also not influenced by
linoleate or palmitoleate.
Discussion
Pro-inflammatory cytokines have well-established detrimental effects on the function and via-
bility of pancreatic β-cells [4,35,52,55]. Our detailed real-time respiratory analysis reported
here reveals functional consequences of cytokine exposure for β-cell oxidative phosphoryla-
tion, and highlights INS-1E cells as powerful model of β-cell bioenergetics. Previously, we pre-
dicted a dual role of mitochondrial uncoupling protein-2 in GSIS regulation and oxidative
stress protection [56], which has proven correct in pancreatic islets [57,58]. Moreover, toxic
nutrient effects on the bioenergetic behaviour of INS-1E cells align closely with those observed
in islets [43]. Our current findings offer novel insight in the effects of cytokines on real-time
mitochondrial function in β-cells and conclusively link a restricted pyruvate oxidation capacity
to cytokine-impaired GSIS. Moreover, our results dissociate inflammatory defects from palmi-
tate-induced defects, and provide clues as to how unsaturated NEFAs may protect against
nutrient-induced β-cell damage.
Mechanism of cytokine-induced GSIS impairment
Mitochondrial ATP synthesis is crucial for nutrient-secretion coupling in β-cells as bioener-
getic fuel sensitivity is responsible for the glucose-induced rise in the cytosolic ATP/ADP ratio
that triggers insulin secretion [47]. Our functional respiratory data reveal that IL-1β plus IFN-
γ impair GSIS by restricting mitochondrial capacity for oxidising pyruvate (Fig 2), which is
consistent with a well-established aconites inhibition by cytokine-induced NO [25,26].
Reported glucokinase inhibition [20–24] unlikely accounts for the inflammatory GSIS pheno-
type we report here (Fig 1A) as glucose- and pyruvate-stimulated electron transfer capacity are
equally sensitive to IL-1β plus IFN-γ. Restricted pyruvate oxidation capacity dampens glucose
sensitivity (Fig 2B) and coupling efficiency of oxidative phosphorylation (Fig 2C), and thus
likely prevents an increase in the ATP/ADP ratio that initiates the electrophysiological events
that are necessary for Ca2+ influx and eventual exocytosis of insulin-containing granules.
Indeed, this pathological order of events (Fig 5) agrees with the lack of cytokine effect on KCl-
induced insulin secretion (Fig 1A). The mechanism by which IL-1β plus IFN-γ inhibit
Mechanisms of cytokine-induced defects in pancreatic beta-cell insulin secretion
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pyruvate oxidation cannot be concluded directly from our data, but NO-involvement is likely
[16,59]. Indeed, aconitase inhibition by NO [25,26] is expected to lower pyruvate oxidation as is
NO inhibition of cytochrome c oxidase [60]. Moreover, cytokine-induced superoxide (Fig 3),
which could arise from several sites [61] following increased reduction of the pyruvate oxidation
apparatus, may react with NO to form peroxynitrite [62] that could exacerbate inflammatory
respiratory dysfunction and consequent GSIS impairment (Fig 5). Our mitochondrial superox-
ide data (Fig 3) are consistent with a well-established ROS involvement in cytokine-induced
Fig 4. Unsaturated NEFAs do not protect against cytokine-induced β-cell failure. Cells were exposed for 24 h to 2 ng/mL IL-1β plus 50 ng/mL IFN-γ (grey
bars) in serum-deprived RPMI containing BSA-conjugated linoleate or palmitoletae, or BSA alone. Control cells were incubated in the same media lacking the
cytokines (black bars). NEFA effects were determined on MitoSOX oxidation rate (A)—normalized to cell number), cell density (B)—normalized to BSA
control not exposed to cytokines, glucose-stimulated coupled mitochondrial respiration (C)—normalized to coupled respiration without added glucose and
GSIS (D). Data are means ± SEM of 4 independent experiments (S1 Data) with each condition repeated 5 times. Mean differences were tested for statistical
significance by 2-way ANOVA:  , ,differs from the control condition (P< 0.05, P< 0.01 and P< 0.0001, respectively).
https://doi.org/10.1371/journal.pone.0199505.g004
Mechanisms of cytokine-induced defects in pancreatic beta-cell insulin secretion
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beta cell failure [21,63–65]. Worth notice, it has been suggested that superoxide may in fact
ameliorate cytokine-provoked β-cell dysfunction by converting NO to peroxynitrite [66].
Palmitate and cytokine phenotypes are mechanistically distinct
Circulating NEFAs and cytokines are considered important molecular mediators that link
obesity to type 2 diabetes [12] through mechanisms that are possibly related. Specifically,
nutrient excess that characterizes obesity has been shown to stimulate the production of pro-
inflammatory cytokines in human islets by NEFA-binding to β-cell toll-like receptors [67] and
Fig 5. Mechanistic model of cytokine-induced GSIS impairment. Pancreatic β-cells respond to a rise in the blood glucose level by increasing their oxidative
metabolism. Pyruvate that results from increased glycolysis is imported to mitochondria by the mitochondrial pyruvate carrier (MPC) and then oxidized by the pyruvate
dehydrogenase complex (PDC) to acetyl-CoA, which fuels the tricarboxylic acid (TCA) cycle. Reducing power generated by these processes is oxidized by the
mitochondrial electron transfer chain (OX) that conserves liberated energy in a protonmotive force (PMF), which drives ADP phosphorylation (PHOS). The
consequent rise in the cytosolic ATP/ADP ratio inhibits ATP-sensitive potassium channels (KATP), decreases the plasma membrane potential (Δψp), opens voltage-gated
calcium channels (VGCC), causes Ca2+ influx, and triggers exocytosis of insulin-containing granules. Exposure to IL-1β plus IFN-γ inhibits mitochondrial pyruvate
oxidation (blue box) likely via activation of inducible nitric oxide synthase (iNOS) and consequent NO formation. Inhibition of pyruvate oxidation dampens
bioenergetic glucose sensitivity and thus attenuates GSIS. Cytokine-induced reactive oxygen species (ROS) are a plausible consequence of inhibited pyruvate oxidation
and may reinforce this inhibition.
https://doi.org/10.1371/journal.pone.0199505.g005
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consequent upregulation of NF-κB signaling [12]. Nutrient surplus further causes β-cell
inflammation by activating the NLRP3 inflammasome [12]. Although IL-1β plus IFN-γ indeed
cause dysfunction and loss of INS-1E cells that appear similar to palmitate-induced defects
[40,43,50,68], our data reveal that the underlying mechanisms are different. Both cytokines
and palmitate cause oxidative phosphorylation defects, but attenuation of GSIS coincides with
deficient ATP synthesis in the case of inflammatory stress (Fig 1), whereas it precedes mito-
chondrial dysfunction in the case of nutrient stress [43]. Furthermore, restricted oxidative
capacity appears the sole cause of cytokine-impaired GSIS (Fig 5), whereas the deleterious pal-
mitate GSIS phenotype is largely owing to stimulation of basal insulin secretion, most likely
secondary to electrophysiological defects [43]. Cytokine effects on electrophysiology and insu-
lin exocytosis are unlikely in our experiments as KCl-induced insulin secretion from INS-1E
cells was not affected by IL-1ß and IFN-γ (Fig 1A). In agreement with [69], we also reveal that
palmitate and cytokines stimulate mitochondrial superoxide production via distinct mecha-
nisms, since palmitate-induced oxidative stress and consequent loss of INS-1E cells are pre-
vented by palmitoleate [40,50], whilst equivalent cytokine phenotypes are unaffected by
palmitoleate and linoleate (Fig 4).
Protection against nutrient-induced β-cell failure
It is generally unclear how unsaturated NEFAs protect against damage caused by their satu-
rated counterparts [70]. As discussed above, the cytokine defects we report here are not pre-
vented by unsaturated NEFAs, which disagrees with observations published by others [35].
This disagreement may arise from experimental differences, which would suggest that protec-
tion by unsaturated NEFAs against inflammatory cell stress is not particularly robust. Because
the design of our palmitate and cytokine experiments is comparable, the differential protection
by unsaturated NEFAs against distinct oxidative stress mechanisms offers clues as to how pal-
mitoleate prevents palmitate-induced cell loss. Specifically, our findings reveal that palmitole-
ate does not prevent ROS from triggering apoptosis, and, therefore, that protection must arise
during ROS production. Both palmitate [40,50] and cytokines Figs 3A and 4A stimulate mito-
chondrial superoxide, but by distinct mechanisms given the differential palmitoleate effect on
the rate of MitoSOX oxidation. Our cytokine exposures likely stimulate superoxide generation
from one or more of the mitochondrial sites that are involved in (restricted) pyruvate oxida-
tion (Fig 5), which include the pyruvate dehydrogenase complex and respiratory complexes I,
II and III [61]. Palmitate exposure is expected to increase ROS production from the same sites
against a background of high glucose [71], but, in addition, may cause superoxide production
from the electron-transferring flavoprotein [61], which reduces the mitochondrial electron
transfer chain during fatty acid β-oxidation. We speculate that unsaturated NEFAs may lower
ROS production from this site.
Conclusion
Our results identify pyruvate oxidation defects as an early step in cytokine-induced GSIS
impairment in INS-1E cells. Given the previous consistency between bioenergetic effects in
INS-1E cells and pancreatic islets (cf. papers cited above), the reported data suggest the mito-
chondrial electron transfer chain as a possible target for therapeutic prevention of pro-inflam-
matory loss of β-cell function and mass. As palmitate- and cytokine-induced defects arise via
distinct mechanisms, multiple pharmacological interventions may be necessary to manage β-
cell failure in obesity. Although the mechanism by which unsaturated NEFAs protect against
obesity-related β-cell loss and dysfunction remains to be elucidated, our data suggest that their
use against inflammatory stress is limited.
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